Dose-response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost.
about
Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical TrialsCharacterization of T-cell responses in macaques immunized with a single dose of HIV DNA vaccineInsertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigensDendritic cells exposed to MVA-based HIV-1 vaccine induce highly functional HIV-1-specific CD8(+) T cell responses in HIV-1-infected individuals.Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition.Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cellsOral Immunization with a Recombinant Lactococcus lactis-Expressing HIV-1 Antigen on Group A Streptococcus Pilus Induces Strong Mucosal Immunity in the Gut.Targeting 4-1BB (CD137) to enhance CD8 T cell responses with poxviruses and viral antigens.Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines.A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines.Comparative studies on in vitro expression and in vivo immunogenicity of supercoiled and open circular forms of plasmid DNA vaccinesImmunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models.Efficacy of a DNA vaccine carrying Eimeria maxima Gam56 antigen gene against coccidiosis in chickensVaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins.
P2860
Q28394899-A94C4371-B078-4501-B55C-9EE2E9FAB1AEQ33614476-7E1E2641-0C03-4293-99BC-67D373508548Q33627613-C45DF3CE-142F-42DE-BCEF-731B6F0651E9Q33916776-77576302-CAE2-4447-B181-C90D3B24F43BQ33967039-A3BBFC67-9355-4DA7-A19B-C72B5A29C004Q34605490-58DA3AEB-8424-44BB-8900-D6B497B42EF4Q36260414-8DCC5DA6-8CB3-46F7-8796-548F23ADF9C5Q36382421-0E79C854-BC54-450B-8282-2E1B3BAE3196Q36488676-D8630CDB-94AF-4B04-9C32-BD1626D091AEQ36494079-39D3D2C3-1236-45C6-81CF-90943BAE67D8Q37217471-50C1BCE5-67F3-4F44-A730-65CFFE5862B3Q40071705-162AB5F0-BF61-4956-BBBD-9D1A67274FCFQ40960320-ED873AE3-FCCB-4CEE-85DC-C16F44D49A93Q47276928-9675F785-2BC7-4FC1-A5C8-108CC56FB6F3
P2860
Dose-response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Dose-response studies for the ...... odified vaccinia Ankara boost.
@en
Dose-response studies for the ...... odified vaccinia Ankara boost.
@nl
type
label
Dose-response studies for the ...... odified vaccinia Ankara boost.
@en
Dose-response studies for the ...... odified vaccinia Ankara boost.
@nl
prefLabel
Dose-response studies for the ...... odified vaccinia Ankara boost.
@en
Dose-response studies for the ...... odified vaccinia Ankara boost.
@nl
P2093
P1433
P1476
Dose-response studies for the ...... odified vaccinia Ankara boost.
@en
P2093
Harriet L Robinson
Jinyan Liu
Linda S Wyatt
Michael Hellerstein
Michael McDonnel
Rama Rao Amara
P304
P356
10.1016/J.VACCINE.2006.05.081
P407
P50
P577
2006-06-09T00:00:00Z